BSEM (BioStem Technologies) Other Stockholders Equity: $-0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSEM BioStem Technologies Inc BSEM
37 GF Score
Price $4.30
! 6 Warning Signs
View Full Analysis

What is BioStem Technologies Other Stockholders Equity?

BioStem Technologies BSEM -2.39% 37 Other Stockholders Equity is $-0.00 Mil as of Jun. 2026. GuruFocus rates BSEM with a GF Score™ of 37/100. The stock has 6 warning signs investors should review.

BioStem Technologies's Other Stockholders Equity for the quarter that ended in Jun. 2026 was $-0.00 Mil.

BioStem Technologies's quarterly Other Stockholders Equity declined from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.00 Mil) and declined from Mar. 2026 ($0.00 Mil) to Jun. 2026 ($-0.00 Mil).

BioStem Technologies's annual Other Stockholders Equity increased from Dec. 2023 ($-0.00 Mil) to Dec. 2024 ($0.00 Mil) and increased from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

BioStem Technologies Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for BioStem Technologies's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioStem Technologies Other Stockholders Equity Chart

BioStem Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 0.00 -0.00 0.00 0.00

BioStem Technologies Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 0.00 0.00 0.00 -0.00
BSEM
37GF Score
BioStem Technologies Inc BSEM
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioStem Technologies Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $-0.00 Mil mean?
BioStem Technologies (BSEM) has a Other Stockholders Equity of $-0.00 Mil as of Jun. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on BioStem Technologies and its competitors.
Is BioStem Technologies' Other Stockholders Equity too high?
BioStem Technologies' current Other Stockholders Equity is $-0.00 Mil. Overall, BioStem Technologies has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does BioStem Technologies' Other Stockholders Equity compare to IBIO and CSBR?
BioStem Technologies' Other Stockholders Equity of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on BioStem Technologies and its competitors. BioStem Technologies's current Other Stockholders Equity is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioStem Technologies stock overvalued right now?
BioStem Technologies (BSEM) has a current Other Stockholders Equity of $-0.00 Mil. The current Other Stockholders Equity is $-0.00 Mil. BioStem Technologies' overall GF Score™ is 37/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Other Stockholders Equity is $-0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioStem Technologies Business Description

Other Exchanges 0JQ:Germany
Address 2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc. is a regenerative medicine company based in the United States that develops, manufactures, and commercializes placental-derived tissue allografts for wound care and other clinical applications. Using its proprietary BioRetain processing method, the company produces perinatal tissue products that preserve the natural extracellular matrix and growth factors found in amniotic and chorionic tissue. Its product portfolio includes branded allografts such as VENDAJE, VENDAJE AC, AmnioWrap2, and AmnioFill, which are used in the treatment of chronic wounds including diabetic foot ulcers, venous leg ulcers, and pressure ulcers, as well as in surgical and orthopedic applications. The company sells primarily to physicians, wound care clinics, hospitals, and healthcare providers across the United States, generating revenue through the sale of its tissue graft products.
37GF Score

Get the complete analysis for BSEM

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.30
Price